Impaired melanoma growth in VASP deficient mice

FEBS Letters

Volumn 585, Issue 15, 2011, Pages 2533-2536

  Kim, Young Min ^a   Renné, Christoph ^b   Seifert, Stefanie ^c   Schuh, Kai ^d   Renné, Thomas ^c  

^a Hannam University   (South Korea)

^b GOETHE UNIVERSITY   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Angiogenesis; Cancer; Cancer therapy; Cytoskeleton; Genetically altered mouse model; Melanoma; VASP; Vessel

Indexed keywords

VASODILATOR STIMULATED PHOSPHOPROTEIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; HISTOPATHOLOGY; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; WILD TYPE;

ANIMALS; CELL ADHESION MOLECULES; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; TRANSPLANTATION, HOMOLOGOUS; TUMOR BURDEN; TUMOR MICROENVIRONMENT;

ANIMALIA; MURINAE; MUS;

EID: 79960912416     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.07.002     Document Type: Article

References (19)

1. Benz, P.M., Blume, C., Seifert, S., Wilhelm, S., Waschke, J., Schuh, K., Gertler, F., Münzel, T. and Renné, T. (2009) Differential VASP phosphorylation controls remodeling of the actin cytoskeleton. J. Cell Sci. 122, 3954-3965.
2. Benz, P.M., Blume, C., Moebius, J., Oschatz, C., Schuh, K., Sickmann, A., Walter, U., Feller, S.M. and Renné, T. (2008) Cytoskeleton assembly at endothelial cell-cell contacts is regulated by aII-spectrin-VASP complexes. J. Cell Biol. 180, 205-219.
3. Krause, M.M., Dent, E.W., Bear, J.E., Loureiro, J.J. and Schuh, K. (2003) ENA/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu. Rev. Cell Dev. Biol. 19, 541-564. (Pubitemid 37487360)
4. Bachmann, C., Fischer, L., Walter, U. and Reinhard, M. (1999) The EVH2 domain of the vasodilator-stimulated phosphoprotein mediates tetramerization, F-actin binding, and actin bundle formation. J. Biol. Chem. 274, 23549-23557.
5. Hauser, W., Knobeloch, K.P., Eigenthaler, M., Gambaryan, S., Krenn, V., Geiger, J., Glazova, M., Rohde, E., Horak, I., Walter, U. and Zimmer, M. (1999) Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice. Proc. Natl. Acad. Sci. USA 96, 8120-8125. (Pubitemid 29328418)
6. Gambaryan, S., Hauser, W., Kobsar, A., Glazova, M. and Walter, U. (2001) Distribution, cellular localization, and postnatal development of VASP and Mena expression in mouse tissues. Histochem. Cell Biol. 116, 535-543. (Pubitemid 34023587)
7. Price, C.J. and Brindle, N.P. (2000) Vasodilator-stimulated phosphoprotein is involved in stress-fiber and membrane ruffle formation in endothelial cells. Arterioscler Thromb. Vasc. Biol. 20, 2051-2056.
8. Furman, C., Sieminski, A.L., Kwiatkowski, A.V., Rubinson, D.A., Vasile, E., Bronson, R.T., Fässler, R. and Gertler, F.B. (2007) Ena/VASP is required for endothelial barrier function in vivo. J. Cell Biol. 179, 761-775. (Pubitemid 350146260)
9. Liu, K., Li, L., Nisson, P.E., Gruber, C., Jessee, J. and Cohen, S.N. (1999) Reversible tumorigenesis induced by deficiency of vasodilator-stimulated phosphoprotein. Mol. Cell Biol. 19, 3696-3703. (Pubitemid 29193829)
10. Han, G., Fan, B., Zhang, Y., Zhou, X., Wang, D.H., Wei, Y., Sun, S., Hu, M., Zhang, J. and Wei, L. (2008) Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells. Oncol. Rep. 20, 929-939.
11. Toyoda, A., Kawana, H., Azuhata, K., Yu, J., Omata, A., Kishi, H., Higashi, M. and Harigaya, K. (2009) Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Int. J. Oncol. 34, 53-60.
12. Hu, L.D., Zou, H.F., Zhan, S.X. and Cao, K.M. (2008) EVL (Ena/VASP-like) expression is up-regulated in human breast cancer and its relative expression level is correlated with clinical stages. Oncol. Rep. 19, 1015-1020.
13. Renné, T., Pozgajová, M., Grüner, S., Schuh, K., Pauer, H.U., Burfeind, P., Gailani, D. and Nieswandt, B. (2005) Defective thrombus formation in mice lacking coagulation factor XII. J. Exp. Med. 202, 271-281. (Pubitemid 41043823)
14. Kayisli, U.A., Demir, R., Erguler, G. and Arici, A. (2002) Vasodilator-stimulated phosphoproteinexpression and its cytokine-mediated regulation in vasculogenesis during human placental development. Mol. Hum. Reprod. 8, 1023-1030. (Pubitemid 35331807)
15. Schlegel, N., Burger, S., Golenhofen, N., Walter, U., Drenckhahn, D. and Waschke, J. (2008) The role of VASP in regulation of cAMP- and Rac 1-mediated endothelial barrier stabilization. Am. J. Physiol. Cell Physiol. 294, 178-188.
16. Fiedler, L.R., Bachetti, T., Leiper, J., Zachary, I. and Chen, L. (2009) The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis. Arterioscler Thromb. Vasc. Biol. 29, 2117-2124.
17. Garcia Arguinzonis, M.I., Galler, A.B., Walter, U., Reinhard, M. and Simm, A. (2002) Increased spreading, Rac/p21-activated kinase (PAK) activity, and compromised cell motility in cells deficient in vasodilator-stimulated phosphoprotein (VASP). J. Biol. Chem. 277, 45604-45610. (Pubitemid 36159171)
18. Philippar, U., Evanthia, T., Matthew, O.R., Yamaguchi, H., Kim, H.D., Giampieri, W.Y., Goswami, S., Wyckoff, J.B., Douglas, A., Sahai, L.E., John, S.C. and Gertler, F.B. (2008) A mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev. Cell. 15, 813-828.
19. Lindsay, S.L., Ramsey, S., Aitchison, M., Renné, T. and Evans, T.J. (2007) Modulation of lamellipodial structure and dynamics by NO-dependent phosphorylation of VASP Ser239. J. Cell Sci. 120, 3011-3021. (Pubitemid 47517084)